By clicking on this link, we may receive a commission. Learn more. Nasal decongestant spray can help relieve sinus infection symptoms in the short term. But you should limit your use to no more ...
In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...
Bumetanide Nasal Spray (RSQ-777) is being developed as a convenient, outpatient-focused therapy for edema associated with congestive heart failure, as well as liver and kidney disease. “We are pleased ...
Here’s how it works. The best Mint Mobile plans deliver low monthly rates but with one big catch — getting the best price means paying for a year of service up front. But if a big lump sum ...
The Mint budgeting app officially shut down on March 23, 2024, and users can no longer access their data on the app. Intuit®, which owns Mint and other personal finance platforms like QuickBooks ...
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback